Hairpin Ribozyme Targeted Vascular Endothelial Growth Factor (VEGF) Inhibited the Expression of VEGF and the Growth of Xenografted Tumors

GUO Zi-jian,YAN Ling-ling,YANG Ji-cheng,XIE Yu-feng,SHENG Wei-hua,HUANG Zhao-hui,WANG Xue-hao,LI Li-hua
DOI: https://doi.org/10.3781/j.issn.1000-7431.2007.10.001
2007-01-01
Tumor
Abstract:Objective:Hepatocarcinoma cell line was transfected with anti-vascular endothelial growth factor(VEGF) hairpin ribozyme gene to observe the effect of hairpin ribozyme on VEGF expression and the growth of the xenografted tumors.Methods:The artificial anti-VEGF hairpin ribozyme gene was transfected into hepatocarcinoma SMMC-7721 cells via lipofectin mediation.The blank vector and the cell controls were prepared simultaneously. Then,positive clones were screened by genticin(G418).The transcription of ribozyme was confirmed by RT-PCR.The effects of the ribozyme on VEGF expression of SMMC-7721cells were detected by semi-quantitative RT-PCR and immunohistochemical method.Cells in each group were inoculated into nude mice.The tumor volume and weight were recorded.The change in microvessel density and expression of VEGF was determined by immunohistochemistry.Results:Ribozyme gene was successfully transferred into tumor cells.The proliferation rate of ribozyme-transfected SMMC-7721 cells was significantly slower(P0.01).The expression of VEGF significantly decreased in ribozyme-transfected SMMC-7721 cells.After rebozyme transfection,the tumor formation rate significantly decreased and the growth speed of xenografted hepatocarcinoma markedly slowed down.The microvessel density and angiogenesis of the xenografted hepatocarcinoma were obviously reduced.Conclusion:Anti-VEGF hairpin ribozyme gene significantly inhibited the VEGF expression of hepatocarcinoma in vitro and in vivo by inhibiting angiogenesis of tumor cells.This study provided an experimental evidence for anti-angiogenesis gene therapy for hepatocarcinoma.
What problem does this paper attempt to address?